Epstein-Barr virus: Biology and clinical disease-Reference-Cited by-同舟云学术

Epstein-Barr virus: Biology and clinical disease

Published:2022-09 Issue:20 Volume:185 Page:3652-3670
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Damania Blossom,Kenney Shannon C.,Raab-Traub Nancy

Funder

National Institutes of Health

Amsterdam Brain and Cognition

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference188 articles.

1. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate;Ablasser;Nat. Immunol.,2009

2. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells;Albanese;Proceedings of the National Academy of Sciences of the United States of America,2016

3. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults;Alexander;International Journal of Cancer,2003

4. Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo;Anderson;Blood,2009

5. Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex;Aubry;J. Virol.,2014

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of dried blood spots for Epstein–Barr virus nucleic acid testing;Journal of Clinical Virology;2024-10

2. HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus;Clinical Microbiology Reviews;2024-09-12

3. Unveiling the Impact of Epstein-Barr Virus on the Risk of Prostate Cancer: A Mendelian Randomization Study;Nutrition and Cancer;2024-09-09

4. The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program;PLOS Pathogens;2024-09-06

5. The Impact of Epstein-Barr Virus on Autoimmune Neuromuscular Disorders: A Comparative Study of Myasthenia Gravis and Guillain–Barre Syndrome;Current Treatment Options in Neurology;2024-09-02